The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
Abstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12902-019-0390-3 |
id |
doaj-343618e11f3441cb9bf704b57b16854d |
---|---|
record_format |
Article |
spelling |
doaj-343618e11f3441cb9bf704b57b16854d2020-11-25T03:37:05ZengBMCBMC Endocrine Disorders1472-68232019-06-011911710.1186/s12902-019-0390-3The captopril challenge test for diagnosing primary Aldosteronism in a Chinese populationKe-ying Zhu0Yan Zhang1Wen-jing Zhang2Hong-yun Li3Wen-huan Feng4Da-long Zhu5Ping Li6Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing Medical University SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolDepartment of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical SchoolAbstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this standard is applicable in Chinese subjects. The aim of the present study was to investigate the post-CCT efficacy of plasma aldosterone concentration (PAC) suppression and determine the post-CCT aldosterone renin activity ratio (ARR) and PAC for PA diagnosis. Methods We recruited 110 consecutive patients with PA, 163 with primary hypertension (PH), and 40 healthy volunteers (NC). The CCT was conducted in all patients. Total sodium intake was estimated from 24-h urinary excretions. ROC curves were used to analyze the efficiency of different CCT diagnostic criteria for diagnosing PA. Results In NC and PH patients, PRA was increased and PAC was decreased post-CCT (P < 0.05). The mean degree of PAC decline after CCT was approximately 9.3%, and only 11.7% of the patients with PH showed a greater than 30% suppression of PAC after CCT. In patients with PA, the post-CCT change in PRA and PRC was slight. The post-CCT degree of PAC decline was unrelated to dietary salt intake. The areas under the ROC for the post-CCT ARR, PAC and PAC suppression % were 0.994, 0.754 and 0.606, respectively. The optimal post-CCT cutoff value for ARR for diagnosing PA was 20, which yielded a sensitivity and specificity of 94.0 and 99.4%, respectively. Conclusions The PAC suppression percentage after CCT recommended by current clinical guidelines is not applicable when diagnosing Chinese subjects with PA. Compared to post-CCT PAC, post-CCT ARR was a better approach, having an optimal cutoff of 20 when interpreting the results of the CCT in Chinese patients. We found no relationship between high salt intake and low responses of the renin-angiotensin system (RAS) to the CCT.http://link.springer.com/article/10.1186/s12902-019-0390-3Primary aldosteronismDiagnosisCaptopril challenge test |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ke-ying Zhu Yan Zhang Wen-jing Zhang Hong-yun Li Wen-huan Feng Da-long Zhu Ping Li |
spellingShingle |
Ke-ying Zhu Yan Zhang Wen-jing Zhang Hong-yun Li Wen-huan Feng Da-long Zhu Ping Li The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population BMC Endocrine Disorders Primary aldosteronism Diagnosis Captopril challenge test |
author_facet |
Ke-ying Zhu Yan Zhang Wen-jing Zhang Hong-yun Li Wen-huan Feng Da-long Zhu Ping Li |
author_sort |
Ke-ying Zhu |
title |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population |
title_short |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population |
title_full |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population |
title_fullStr |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population |
title_full_unstemmed |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population |
title_sort |
captopril challenge test for diagnosing primary aldosteronism in a chinese population |
publisher |
BMC |
series |
BMC Endocrine Disorders |
issn |
1472-6823 |
publishDate |
2019-06-01 |
description |
Abstract Background The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA). Guidelines show that plasma aldosterone is normally suppressed by captopril (> 30%) in primary hypertension (PH) and in healthy people. It is unclear whether this standard is applicable in Chinese subjects. The aim of the present study was to investigate the post-CCT efficacy of plasma aldosterone concentration (PAC) suppression and determine the post-CCT aldosterone renin activity ratio (ARR) and PAC for PA diagnosis. Methods We recruited 110 consecutive patients with PA, 163 with primary hypertension (PH), and 40 healthy volunteers (NC). The CCT was conducted in all patients. Total sodium intake was estimated from 24-h urinary excretions. ROC curves were used to analyze the efficiency of different CCT diagnostic criteria for diagnosing PA. Results In NC and PH patients, PRA was increased and PAC was decreased post-CCT (P < 0.05). The mean degree of PAC decline after CCT was approximately 9.3%, and only 11.7% of the patients with PH showed a greater than 30% suppression of PAC after CCT. In patients with PA, the post-CCT change in PRA and PRC was slight. The post-CCT degree of PAC decline was unrelated to dietary salt intake. The areas under the ROC for the post-CCT ARR, PAC and PAC suppression % were 0.994, 0.754 and 0.606, respectively. The optimal post-CCT cutoff value for ARR for diagnosing PA was 20, which yielded a sensitivity and specificity of 94.0 and 99.4%, respectively. Conclusions The PAC suppression percentage after CCT recommended by current clinical guidelines is not applicable when diagnosing Chinese subjects with PA. Compared to post-CCT PAC, post-CCT ARR was a better approach, having an optimal cutoff of 20 when interpreting the results of the CCT in Chinese patients. We found no relationship between high salt intake and low responses of the renin-angiotensin system (RAS) to the CCT. |
topic |
Primary aldosteronism Diagnosis Captopril challenge test |
url |
http://link.springer.com/article/10.1186/s12902-019-0390-3 |
work_keys_str_mv |
AT keyingzhu thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT yanzhang thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT wenjingzhang thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT hongyunli thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT wenhuanfeng thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT dalongzhu thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT pingli thecaptoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT keyingzhu captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT yanzhang captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT wenjingzhang captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT hongyunli captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT wenhuanfeng captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT dalongzhu captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation AT pingli captoprilchallengetestfordiagnosingprimaryaldosteronisminachinesepopulation |
_version_ |
1724547301779701760 |